Soleno Therapeutics (SLNO) Times Interest Earned (2013 - 2026)
Soleno Therapeutics' (SLNO) quarterly Times Interest Earned came in at $1.15 in Q1 2026, up 103.42% year-on-year from $0.56 in Q1 2025, and down 96.47% on a QoQ basis from $32.49 in Q4 2025.
Soleno Therapeutics (SLNO) Times Interest Earned (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 14 years of Times Interest Earned data on file, last reported at $1.15 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 103.42% year-over-year to $1.15 in Q1 2026; TTM through Mar 2026 was $3.17, a 101.81% increase from a year earlier, with the FY2025 full-year figure at $0.12, up 105.24% from the prior year.
- Times Interest Earned for Q1 2026 stood at $1.15, down from $32.49 in the prior quarter.
- Over the last five years, Times Interest Earned for SLNO reached as high as $3477.4 in Q4 2024 and fell as low as -$16208.6 in Q2 2023.
- Historically, Times Interest Earned has averaged -$753.43 across 5 years, with a median of -$0.3 in 2024.
- On a YoY basis, Times Interest Earned climbed as much as 53650.64% in 2023 and fell as far as 84541.7% in 2023.
- Year by year, Times Interest Earned stood at -$0.1 in 2022, then surged by 53650.64% to $52.69 in 2023, then soared by 6499.83% to $3477.4 in 2024, then sank by 99.07% to $32.49 in 2025, then sank by 96.47% to $1.15 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were $1.15 in Q1 2026, $32.49 in Q4 2025, and $0.19 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | 1.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 |
| Dec 31, 2025 | 32.49 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | -0.04 |
| Mar 31, 2025 | -33.61 |
| Dec 31, 2024 | 3,477.41 |
| Sep 30, 2024 | -0.83 |
| Jun 30, 2024 | -0.35 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | 52.69 |
| Sep 30, 2023 | -0.22 |
| Jun 30, 2023 | -16,208.65 |
| Mar 31, 2023 | -71.17 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -25.04 |
| Jun 30, 2022 | -19.15 |
| Mar 31, 2022 | -12.83 |
| Dec 31, 2021 | -0.06 |
| Sep 30, 2021 | -167.08 |
| Jun 30, 2021 | -18.06 |